Daewoong Pharmaceutical Presents Phase 2 Clinical Trial Poster on 'Bersiporocin' at ATS 2025, Highlights Global Patient Demographics ...Middle East

- Ongoing Phase 2 study enrolling 102 patients in the U.S. and South Korea, with more than 50% of participants identified as Asian - Selectively inhibits collagen synthesis via PRS targeting, aiming to suppressing fibrosis progression SEOUL, June 4, 2025 /PRNewswire/ -- Daewoong...

Read More Details
Finally We wish PressBee provided you with enough information of ( Daewoong Pharmaceutical Presents Phase 2 Clinical Trial Poster on 'Bersiporocin' at ATS 2025, Highlights Global Patient Demographics )

Also on site :

• George Strait, 73, Goes Viral for Wildly Generous Gift to Wounded Military Veteran
• Two Minors Admit to Felony Charges following Bomb and Shooting Threat at Ventura High School
• 2000s Rock Icon Makes Jaw-Dropping Career Move & Fans Are Here for It